The myeloperoxidase system of human phagocytes generates N(ε)- (carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 103-113

  Anderson, Melissa M ^a   Requena, Jesús R ^b   Crowley, Jan R ^a   Thorpe, Suzanne R ^b   Heinecke, Jay W ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Box 8046   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LYSINE DERIVATIVE; MYELOPEROXIDASE;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PHAGOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MODIFICATION;

EID: 0032694683     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3042     Document Type: Article

References (61)

1. Esterbauer, H.R., Schaur, J., and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
2. Baynes, J.W. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405-412.
3. Monnier, V.M., Sell, D.R., Nagaraj, R.H., and Miyata, S. 1991. Mechanisms of protection against damage mediated by the Maillard reaction in aging. Gerontology. 37:152-165.
4. Berliner, J.A., and Heinecke, J.W. 1996. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:707-727.
5. Witz, G. 1989. Biological intetactions of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 7:333-349.
6. Thornally, P.J. 1996. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27:565-573.
7. Monnier, V.M., and Cerami, A. 1981. Nonenzymatic browning in vivo: possible processes for aging of long-lived proteins. Science. 211:491-493.
8. Brownlee, M., Cerami, A., and Vlassara, H. 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321.
9. ε-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated proteins. J. Biol. Chem. 61:4889-4894.
10. Sell, D.R., and Monnier, V.M. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix: implications of pentoses in the aging process. J. Biol. Chem. 264:21597-21602.
11. Dyer, D.G., et al. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:2463-2469.
12. McCance, D.R., et al. 1993. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91:2470-2478.
13. Monnier, V.M., Glomb, M., Elgawish, A., and Sell, D.R. 1996. The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution. Diabetes. 45(Suppl. 3):S67-S72.
14. Ledl, F., and Schleicher, E. 1990. New aspects of the Maillard reaction in foods and in the human body. Angew. Chem. Int. Ed. Engl. 29:565-594.
15. Maillard, L.C. 1912. Action des acides amines sur les sucres: formation des melaniodines par voie merhodique. C.R. Acad. Sci. 154:66-68.
16. Glomb, M.A., and Monnier, V.M. 1995. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270:10017-10026.
17. Geoghegan, K.F., Ybarra, D.M., and Feeney, R.E. 1979. Reversible reductive alkylation of amino groups in proteins. Biochemistry. 18:5392-5399.
18. Acharya, A.S., and Manning, J.M. 1983. Reaction of glycolaldehyde with proteins: latent crosslinking potential of α-hydroxyaldehydes. Proc. Natl. Acad. Sci. USA. 80:3590-3594.
19. Klebanoff, S.J. 1980. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93:480-489.
20. Harrison, J.E., and Schultz, J. 1976. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374.
21. Foote, C.S., Goyne, T.E., and Lehrer, R.I. 1981. Assessment of chlorination by human neutrophils. Nature. 301:715-716.
22. Test, S.T., Lampert, M.B., Ossanna, P.J., Thoene, J.G., and Weiss, S.J. 1984. Generation of nitrogen-chloride oxidants by human phagocytes. J. Clin. Invest. 74:1341-1349.
23. Thomas, E.L., Grisham, M.B., and Jefferson, M.M. 1986. Preparation and characterization of chloramines. Methods Enzymol. 132:569-585.
24. Zgliczynski, J.M., Stelmaszynska, T., Domanski, J., and Ostrowski, W. 1971. Chloramines as intermediates of oxidation teactions of amino acids by myeloperoxidase. Biochim. Biophys. Acta. 235:419-424.
25. --mediated aldehyde formation and its relationship to antimicrobial activity. Infect. Immun. 3:595-602.
26. Hazen, S.L., Hsu, F.F., and Heinecke, J.W. 1996. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: a chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J. Biol. Chem. 271:1861-1867.
27. - system to oxidize α-amino acids to a family of reactive aldehydes: mechanistic stucies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 273:4997-5005.
28. Anderson, M.M., Hazen, S.L., Hsu, F.F., and Heinecke, J.W. 1997. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. J. Clin. Invest. 99:424-432.
29. Heinecke, J.W., Li, W., Daehnke, H.L., III, and Goldstein, J.A. 1993. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268:4069-4077.
30. Rakita, R.M., Michel, B.R., and Rosen, H. 1990. Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry. 29:1075-1080.
31. Morita, Y., Iwamoto, H., Aibara, S., Kobayashi, T., and Hasegawa, E. 1986. Crystallization and properties of myeloperoxidase from normal leukocytes. J. Biochem. 99:761-770.
32. Heinecke, J.W., Li, W., Francis, G.A., and Goldstein, J.A. 1993. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J. Clin. Invest. 91:2866-2872.
33. Linder, M.C. 1992. Nutritional biochemistry and metabolism. Elsevier Science. New York, NY. 98.
34. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
35. Knecht, K.J., et al. 1991. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 40:190-196.
36. Leeuwenburgh, C.L., et al. 1997. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:3520-3526.
37. Nelson, D.P., and Kiesow, L.A. 1972. Enthalpy of decomposition of hydrogen peroxide by catalase at 25°C. Anal. Biochem. 49:474-478.
38. Morris, J.C. 1966. The acid ionization constant of HOC1 from 5-35 degrees. J. Phys. Chem. 70:3798-3805.
39. Wells-Knecht, M.C., Thorpe, S.R., and Baynes, J.W. 1995. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:15134-15141.
40. Buertner, G.R. 1993. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300:535-543.
41. Weiss, S.J., Klein, R., Slivka, A., and Wei, M. 1982. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.
42. Winterbourn, C.C. 1985. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta. 840:204-210.
43. Heinecke, J.W., Baker, L., Rosen, H., and Chait, A. 1986. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:757-761.
44. Nikt, E., Saito, T., Kawakami, A., and Kamiya, Y. 1984. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C.J. Biol. Chem. 259:4177-4182.
45. Watson, J.T. 1990. Selected-ion measurements. Methods Enzymol. 193:86-106.
46. Hazen, S.L., Hsu, F.F., d'Avignon, A., and Heinecke, J.W. 1998. Human neurrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry. 37:6864-6873.
47. Heinecke, J.W., Li, W., Mueller, D.M., Bohrer, A., and Turk, J. 1994. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry. 33:10127-10136.
48. Daugherty, A., Dunn, J.L., Rateri, D.L., and Heinecke, J.W. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444.
49. Schleicher, E.D., Wagner, E., and Nerlich, A.G. 1997. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:457-468.
50. Palinski, W., et al. 1995. Immunological evidence for the presence of advanced glycation end products in atherosclerotic lesions of euglycemic rabbits. Arteroscler. Thromb. Vasc. Biol. 15:571-582.
51. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:9982-9986.
52. Wells-Knecht, K.J., Zyzak, D.V., Litchfield, J.E., Thorpe, S.R., and Baynes, J.W. 1995. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in autoxidative modification of proteins by glucose. Biochemistry. 34:3702-3709.
53. Schmidt, A.M., et al. 1996. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 45:S77-S80.
54. Van, S.D., et al. 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:9889-9897.
55. Kato, H., Cho, R.K., Okitani, A., and Hayase, F. 1987. Responsibility of 3-deoxyglucosone for the glucose-induced polymerization of proteins. Agric. Biol. Chem. 51:683-689.
56. Knecht, K.J., Feather, M.S., and Baynes, J.W. 1992. Detection of 3-deoxyfructose and 3-deoxyglucose in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. Arch. Biochem. Biophys. 294:130-137.
57. Liggins, J., and Furth, A.J. 1997. Role of protein-bound carbonyl groups in the Formation of advanced glycation end products. Biochim. Biophys. Acta. 1361:123-130.
58. Rodriguez-Garcia, J., Requena, J.R., and Rodríguez-Segade, S. 1998. Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin. Chem. 44:250-255.
59. Takahashi, M., Suzuki, M., Miyamoto, S., and Inoue, T. 1997. Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br. J. Rheumatol. 36:637-642.
60. Katsunori, H., et al. 1997. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J. Clin. Invest. 100:2995-3004.
61. Giardino, I., Edelstein, D., and Brownlee, M. 1996. BCL-2 expression or antioxidants prevent hyperglycemia induced formation of intracellular advanced glycation end products in bovine endothelial cells. J. Clin. Invest. 97:1422-1428.